Polyoxyethylene hydrogenated castor oil modulates benzalkonium chloride toxicity: comparison of acute corneal barrier dysfunction induced by travoprost Z and travoprost.
Masafumi Uematsu, Takeshi Kumagami, Kenichiro Shimoda, Mao Kusano, Mugen Teshima, Hideto To, Takashi Kitahara, Takashi Kitaoka, Hitoshi Sasaki
Index: J. Ocul. Pharmacol. Ther. 27(5) , 437-44, (2011)
Full Text: HTML
Abstract
To determine the element that modulates benzalkonium chloride (BAC) toxicity by using a new electrophysiological method to evaluate acute corneal barrier dysfunction induced by travoprost Z with sofZia (Travatan Z(®)), travoprost with 0.015% BAC (Travatan(®)), and its additives.Corneal transepithelial electrical resistance (TER) was measured in live white Japanese rabbits by 2 Ag/AgCl electrodes placed in the anterior aqueous chamber and on the cornea. We evaluated corneal TER changes after a 60-s exposure to travoprost Z, travoprost, and 0.015% BAC. Similarly, TER changes were evaluated after corneas were exposed for 60 s to the travoprost additives ethylenediaminetetraacetic acid disodium salt, boric acid, mannitol, trometamol, and polyoxyethylene hydrogenated castor oil 40 (HCO-40) with or without BAC. Corneal damage was examined after exposure to BAC with or without travoprost additives using scanning electron microscopy (SEM) and a cytotoxicity assay.Although no decreases of TER were noted after exposure to travoprost Z with sofZia and travoprost with 0.015% BAC, a significant decrease of corneal TER was observed after 0.015% BAC exposure. With the exception of BAC, no corneal TER decreases were observed for any travoprost additives. After corneal exposure to travoprost additives with BAC, HCO-40 was able to prevent the BAC-induced TER decrease. SEM observations and the cytotoxicity assay confirmed that there was a remarkable improvement of BAC-induced corneal epithelial toxicity after addition of HCO-40 to the BAC.Travoprost Z with sofZia and travoprost with BAC do not induce acute corneal barrier dysfunction. HCO-40 provides protection against BAC-induced corneal toxicity.
Related Compounds
Related Articles:
Formulation and biopharmaceutical evaluation of silymarin using SMEDDS.
2007-01-01
[Arch. Pharm. Res. 30(1) , 82-9, (2007)]
Preparation and evaluation of self-nanoemulsifying tablets of carvedilol.
2009-01-01
[AAPS PharmSciTech 10(1) , 183-92, (2009)]
2011-10-07
[J. Chromatogr. A. 1218(40) , 7166-72, (2011)]
2003-01-01
[J. Drug Target. 11(1) , 37-43, (2003)]
Formulation of parenteral microemulsion containing itraconazole.
2007-01-01
[Arch. Pharm. Res. 30(1) , 114-23, (2007)]